Constant V M相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Changes in neurologists' treatment preferences for Parkinson's disease in the Netherlands

荷兰神经科医生对帕金森病治疗偏好的变化

期刊:Clinical Parkinsonism Related Disorders

影响因子:1.8

doi:10.1016/j.prdoa.2024.100241

Verschuur, Constant V M; Suwijn, Sven R; de Bie, Rob M A

发表日期：2024

文献求助收藏

Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson's Disease

帕金森病早期左旋多巴治疗的成本效益和成本效用

期刊:Journal of Parkinsons Disease

doi:10.3233/JPD-223247

Verschuur, Constant V M; Suwijn, Sven R; de Haan, Rob J; Boel, Judith A; Post, Bart; Bloem, Bas R; van Hilten, Johannes J; van Laar, Teus; Tissingh, Gerrit; Munts, Alexander; Dijkgraaf, Marcel G W; de Bie, Rob M A

发表日期：2022

文献求助收藏

Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD)

临床体征在识别扫描结果无多巴胺能缺乏证据的患者中的价值（SWEDD）

期刊:Journal of Parkinsons Disease

doi:10.3233/JPD-202090

Suwijn, Sven R; Samim, Hamdia; Eggers, Carsten; Espay, Alberto J; Fox, Susan; Lang, Anthony E; Samuel, Mike; Silverdale, Monty; Verschuur, Constant V M; Dijk, Joke M; Verberne, Hein J; Booij, Jan; de Bie, Rob M A

发表日期：2020

文献求助收藏

Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [(123)I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson's disease

非核医学专家医师视觉评估的可靠性以及神经科医师对早期未接受药物治疗的帕金森病患者进行[(123)I]FP-CIT SPECT显像适应症的合理性

期刊:Ejnmmi Research

doi:10.1186/s13550-019-0537-2

Suwijn, Sven R; Verschuur, Constant V M; Slim, Marleen A; Booij, Jan; de Bie, Rob M A

发表日期：2019

文献求助收藏

Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study

一项针对早期帕金森病患者左旋多巴治疗的随机、延迟启动、双盲、安慰剂对照、多中心试验方案：LEAP研究

期刊:BMC Neurology

影响因子:2.2

doi:10.1186/s12883-015-0491-1

Verschuur, Constant V M; Suwijn, S R; Post, B; Dijkgraaf, M; Bloem, B R; van Hilten, J J; van Laar, T; Tissingh, G; Deuschl, G; Lang, A E; de Haan, R J; de Bie, R M A

发表日期：2015

文献求助收藏